Affiliation:
1. Research Clinical Institute of Childhood of the Ministry of Health of the Moscow Region; Research Center for Medical Genetics
2. National Medical Research Center of Transplantology and Artificial Organs named after V. I. Shumakov
3. National Medical Research Center of Transplantology and Artificial Organs named after V. I. Shumakov; I.M. Sechenov First Moscow State Medical University of the Ministry of Healthcare of the Russian Federation
Abstract
Cystic fibrosis (CF) is a severe progressive hereditary disease associated with mutations in the CFTR gene, characterized by multiple organ pathology, including the upper and lower respiratory tract, gastrointestinal and reproductive tracts, and the endocrine system. Despite new therapy, which significantly increases survival among patients with cystic fibrosis, the development of complications of this disease is still a factor affecting the duration and quality of life. The aim of the study is to demonstrate a clinical case of severe course of cystic fibrosis in a patient with meconium ileus, cystic fibrosis-associated diabetes mellitus, pulmonary and arterial hypertension, cirrhosis, who was under the observation of specialists of the Department of Cystic fibrosis of the Research Clinical Institute of Childhood of the Ministry of Health of the Moscow Region and National Medical Research Center of Transplantology and Artificial Organs named after V. I. Shumakov and underwent death donor liver transplantation. New methods of diagnosis and therapy of complications allow timely detection and control of their course, while maintaining a satisfactory quality of life for the patient
Publisher
LLC Global Media Technology
Reference10 articles.
1. Register of patients with cystic fibrosis in the Russian Federation 2021 / Editors S. A. Krasovsky, M. A. Starinova, A. Yu. Voronkova, E. L. Amelina, N. Yu. Kashirskaya, E. I. Kondratyeva, L. P. Nazarenko. St. Petersburg: Charitable Foundation “Ostrova”, 2023, 81 p. (in Russ.)@@ Registr patsientov s mukovistsidozom v Rossiiskoi Federatsii. 2021 god. / Pod redaktsiei S. A. Krasovskogo, M. A. Starinovoi, A. Yu. Voronkovoi, E. L. Amelinoi, N. Yu. Kashirskoi, E. I. Kondrat'evoi, L. P. Nazarenko - SPb.: Blagotvoritel'nyi fond «Ostrova», 2023, 81 s.
2. Terliesner N., Vogel M., Steighardt A. et al. Cystic-fibrosis related-diabetes (CFRD) is preceded by and associated with growth failure and deteriorating lung function. J Pediatr Endocrinol Metab. 2017 Aug 28;30(8):815-821. doi: 10.1515/jpem-2017-0005.
3. Jacquot J., Delion M., Gangloff S., Braux J., Velard F. Bone disease in cystic fibrosis: new pathogenic insights opening novel therapies. Osteoporos Int. 2016 Apr;27(4):1401-1412. doi: 10.1007/s00198-015-3343-3.
4. Polyakov D. P., Pogodina A. A., Kondrat’eva E. I., Voronkova A. Yu., Petrov A. S. Effect of targeted therapy for cystic fibrosis on course of pediatric chronic rhinosinusitis: first russian experience.Russian Otorhinolaryngology. 2023;22(3):86-92. (in Russ.) doi: 10.18692/1810-4800-2023-3-86-92.@@ Polyakov D. P., Pogodina A. A., Kondrat'eva E. I., Voronkova A. Yu., Petrov A. S. Vliyanie targetnoi terapii mukovistsidoza na techenie khronicheskogo rinosinusita u rebenka: pervyi rossiiskii opyt. Rossiiskaya otorinolaringologiya. 2023;22(3):86-92. doi: 10.18692/1810-4800-2023-3-86-92.
5. Klotter V., Gunchick C., Siemers E., Rath T., Hudel H., Naehrlich L., Roderfeld M., Roeb E. Assessment of pathologic increase in liver stiffness enables earlier diagnosis of CFLD: Results from a prospective longitudinal cohort study. PLoS One. 2017 Jun 2;12(6): e0178784. doi: 10.1371/journal.pone.0178784.